EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-SA 4.0

Hypogonadotropic hypogonadism as a cause of NOA and its treatment

Gianmaria Salvio, Giancarlo Balercia, Ates Kadioglu

Asian Journal of Andrology · 2025

DOI: 10.4103/aja202483 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Asian Journal of Andrology, 2025. Verfasst von Gianmaria Salvio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona 60126, Italy. Hauptthemen laut MEDLINE: Hypogonadism, Azoospermia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypogonadotropic hypogonadism (HH) represents a relatively rare cause of nonobstructive azoospermia (NOA), but its knowledge is crucial for the clinical andrologists, as it represents a condition that can be corrected with medical therapy in 3 quarters of cases. There are forms of congenital HH, whether or not associated with an absent sense of smell (anosmic HH or Kallmann syndrome, and normosmic HH, respectively), and forms of acquired HH. In congenital HH, complete absence of pubertal development is characteristic. On the other hand, if the deficit occurs after the time of pubertal development, as in acquired HH patients, infertility and typical symptoms of late-onset hypogonadism are the main reasons for seeking medical assistance. Gonadotropin-releasing hormone (GnRH) or gonadotropin replacement therapy is the mainstay of drug therapy and offers excellent results, although a small but significant proportion of patients do not achieve sufficient responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypogonadismAzoospermiaHumansMaleGonadotropin-Releasing HormoneKallmann SyndromeHormone Replacement Therapy

Stichwörter der Autor:innen

Kallmann syndromegonadotropinshypogonadotropic hypogonadismidiopathic hypogonadism

Substanzen

Gonadotropin-Releasing Hormone

Autor:innen und Institutionen

  • Endocrinology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona 60126, Italy.
  • Section of Andrology, Department of Urology, Istanbul School of Medicine, Istanbul 34093, Türkiye.

Zitieren

APA

Salvio, G., Balercia, G., & Kadioglu, A. (2025). Hypogonadotropic hypogonadism as a cause of NOA and its treatment. Asian Journal of Andrology. https://doi.org/10.4103/aja202483

Vancouver

Salvio G, Balercia G, Kadioglu A. Hypogonadotropic hypogonadism as a cause of NOA and its treatment. Asian Journal of Andrology. 2025. doi:10.4103/aja202483

BibTeX
@article{Salvio2025,
  author = {Salvio, Gianmaria and Balercia, Giancarlo and Kadioglu, Ates},
  title = {Hypogonadotropic hypogonadism as a cause of NOA and its treatment},
  journal = {Asian Journal of Andrology},
  year = {2025},
  doi = {10.4103/aja202483}
}
Kostenlos starten →